Roche Holding AG (XSWX:ROP) Cash Flow for Dividends: CHF-7,731 Mil (TTM As of Dec. 2025)


XSWX:ROP Roche Holding AG XSWX:ROP
79 GF Score
Price CHF332.00
GF Value CHF264.69
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Roche Holding AG Cash Flow for Dividends?

Roche Holding AG XSWX:ROP +2.09% 79 Cash Flow for Dividends is CHF-7,731 Mil as of Dec. 2025. GuruFocus rates XSWX:ROP with a GF Score™ of 79/100 and a GF Value™ of CHF264.69 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Roche Holding AG's cash flow for dividends for the six months ended in Dec. 2025 was CHF0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-7,731 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Roche Holding AG's quarterly payment of dividends increased from Dec. 2024 (CHF0 Mil) to Jun. 2025 (CHF-7,731 Mil) but then declined from Jun. 2025 (CHF-7,731 Mil) to Dec. 2025 (CHF0 Mil).

Roche Holding AG's annual payment of dividends increased from Dec. 2023 (CHF-7,590 Mil) to Dec. 2024 (CHF-7,650 Mil) and increased from Dec. 2024 (CHF-7,650 Mil) to Dec. 2025 (CHF-7,731 Mil).

Roche Holding AG Cash Flow for Dividends Related Terms

Roche Holding AG Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Cash Flow for Dividends Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7,773.00 -7,446.00 -7,590.00 -7,650.00 -7,731.00

Roche Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -7,650.00 0.00 -7,731.00 0.00
XSWX:ROP
79GF Score
Roche Holding AG XSWX:ROP
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roche Holding AG Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-7,731 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of CHF-7,731 Mil mean?
Roche Holding AG (XSWX:ROP) has a Cash Flow for Dividends of CHF-7,731 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Roche Holding AG and its competitors.
Is Roche Holding AG's Cash Flow for Dividends too high?
Roche Holding AG's current Cash Flow for Dividends is CHF-7,731 Mil. Overall, Roche Holding AG has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Cash Flow for Dividends compare to LLY and JNJ?
Roche Holding AG's Cash Flow for Dividends of CHF-7,731 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Roche Holding AG and its competitors. Roche Holding AG's current Cash Flow for Dividends is CHF-7,731 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (XSWX:ROP) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF264.69, compared to a current price of CHF332.00 — trading 25.4% above its estimated fair value. The current Cash Flow for Dividends is CHF-7,731 Mil. Roche Holding AG's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Roche Holding AG (XSWX:ROP), the current Cash Flow for Dividends is CHF-7,731 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (XSWX:ROP) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF332.00 is trading 25.4% above its estimated GF Value™ of CHF264.69. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for XSWX:ROP:

  • Cash Flow for Dividends: CHF-7,731 Mil
  • GF Value™: CHF264.69 vs. price of CHF332.00 (25.4% above fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ROP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
79GF Score

Get the complete analysis for XSWX:ROP

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF332.00
Price
CHF264.69
GF Value